Volume 22, Issue S1 pp. 90-94
INVITED REVIEW

Is granulomatosis with polyangiitis in Asia different from the West?

Godasi S. R. S. N. K. Naidu

Godasi S. R. S. N. K. Naidu

Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Search for more papers by this author
Durga Prasanna Misra

Durga Prasanna Misra

Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Search for more papers by this author
Manish Rathi

Manish Rathi

Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Search for more papers by this author
Aman Sharma

Corresponding Author

Aman Sharma

Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Correspondence

Aman Sharma, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Email: [email protected]

Search for more papers by this author
First published: 18 October 2018
Citations: 25

Abstract

The incidence and clinical features of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) have been shown to vary according to geographical areas, with granulomatosis with polyangiitis (GPA) being more common in northern Europe and microscopic polyangiitis (MPA) being more common in Asian countries. The annual incidence of GPA among Asians varies between 0.37/million to 2.1/million population. The prevalence of GPA has been estimated to be 1.94/100 000 in a Chinese population. Polymorphisms in class II major histocompatibility genes and ETS1 proto-oncogene has been shown in Asian patients with GPA. There is a difference in mean age at onset and proteinase 3 (PR3) or myeloperoxidase (MPO) positivity in GPA patients from different Asian countries. Those from India had mean age of 40 years and those from Japan had mean age of 65 years. Sixty percent of GPA patients from China and Japan were MPO ANCA positive while the majority of patients from India and Korea were PR3 positive. Geographical variation with lower frequency of renal involvement in Indian studies and higher frequency in Chinese patients has also been noted. Treatment outcomes have been similar to those reported from other parts of the world. Remission was achieved in about two-thirds of patients while relapses were noted in one-third to half of the patients. Apart from minor differences in the organ systems involved, MPO-ANCA GPA and PR3-ANCA GPA had similar rates of remission and relapses.

CONFLICT OF INTEREST

None.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.